Dendrimers as drug delivery systems for oncotherapy: Current status of promising applications

Area of Science:

• Nanotechnology
• Oncology
• Materials Science

Background:

• Cancer presents significant global health challenges, with existing treatments facing limitations like toxicity and poor bioavailability.
• There is a critical need for safer, more effective, and selective anticancer agents.
• Dendrimers, as versatile nanocarriers, offer potential solutions to overcome drug delivery challenges in oncology.

Purpose of the Study:

• To review the recent advancements (last two years) in the application of dendrimers for oncological treatment.
• To highlight the importance and effectiveness of dendrimers as drug delivery systems in developing novel cancer therapies.

Main Methods:

• Literature review focusing on publications from the last two years.
• Analysis of dendrimer applications in various nanomedicine formulations for cancer therapy.

Main Results:

• Dendrimers demonstrate versatility in designing nanovaccines, lipophilic/amphiphilic complexes, and smart nanocomplexes.
• These nanocarriers can address physicochemical and pharmacokinetic limitations of conventional anticancer drugs.
• Recent studies showcase dendrimers' potential in enhancing drug selectivity and efficacy.

Conclusions:

• Dendrimers represent a promising platform for developing next-generation cancer therapeutics.
• Their unique properties facilitate improved drug delivery, potentially leading to more targeted and less toxic cancer treatments.
• Continued research into dendrimer-based systems is crucial for advancing oncological treatment strategies.